WarenkorbDrucken
Falk Foundation | Dr. Falk
You are here:  About usCompanySales and Marketing
Affiliates and Business Partners

Europe

North and Central America

South America

Africa

Orient

Asia

Australia


Sales and Marketing

The central principle of Dr. Falk Pharma's marketing concept is to provide doctors, pharmacists and patients with the most up-to-date and impartial information about the state of knowledge concerning diseases and therapies in gastroenterology and hepatology. The decision not to have a large field force is a conscious one. The cornerstone of our efforts is the Falk Foundation’s wide range of international symposia, cross-regional seminars, gastro-forums and regional postgraduate courses as well as a comprehensive literature service (Falk Foundation e.V.). The company also works in close partnership with many national and international medical societies and patient associations.

Germany continues to be Dr. Falk Pharma’s main market. Around a third of all our pharmaceutical products are sold here. However, growth abroad is currently stronger than on the domestic market, and is concentrated mainly in Western and Eastern Europe. Subsidiary companies have been established in some selected European countries. Dr. Falk Pharma now has bases in the Netherlands, Belgium and Luxembourg, Great Britain and Ireland, Portugal, Spain and Russia. We also work closely with trusted, long-standing sales partners in many other countries within Europe and beyond (Affiliates and Business Partners).


Patienten für laufende Studie zu MORBUS CROHN gesucht!

Klinische Studie zur Beurteilung eines neuen, sich in der Erprobung befindlichen biologischen Medikaments. Der Name der Studie ist TRUST-2, was für „TRichUris Suis ova Trial“ steht.

Mehr als 200 Patienten mit MORBUS CROHN haben das sich in der Erprobung befindende Studienmedikament bisher in klinischen Studien eingenommen.

Die Studien zeigen eine Abnahme der Krankheitsaktivität und in der Mehrzahl der Fälle wurde Remission (beschwerdefreie Phase) erzielt. Die bisher beobachteten Nebenwirkungen betrafen zumeist den Verdauungstrakt.